Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > David Goren needs to be held accountable !!!

<< Previous

Bullboard Posts

Next >>

Comment by HIKER2013on Dec 06, 2020 8:20pm

80 Views

Post# 32047153

RE:RE:David Goren needs to be held accountable !!!

bIG Licka, whey do you keep writing to yourself. Are you that lonely..

Make good with Goren and be his friend.

Goren is a very patient and deliberate individual; undoubtedly wants to be sure all the t's have been crossed and the i's dotted. No doubt there is a purpose to how he is managing things n financing and the science of the trials.

HR

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario